AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24149005 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with baseline severity
Number of subjects: 2569
Study 24149005 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Rankin Scale of 5
Number of subjects: 2569
Study 21277837 — intervention group
Group type: EXPERIMENTAL
Intervention: Aceclofenac-CR (n = 143) once daily
Number of subjects: 285
Study 21277837 — intervention group
Group type: COMPARATOR
Intervention: Conventional aceclofenac (n = 142) twice daily
Number of subjects: 285
Study 19561174 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports injury prevention training program
Number of subjects: 22
Study 19561174 — intervention group
Group type: COMPARATOR
Intervention: Control group (regular training program)
Number of subjects: 22
Study 19561174 — intervention group
Group type: COMPARATOR
Intervention: Comparison of experimental and control groups after training
Number of subjects: 22
Study 17785487 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to practice guidelines
Number of subjects: 1131
Study 14998803 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 11778097 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous cervical plexus block with ropivacaine 0.75% 2.5 mg/kg
Number of subjects: 90
Study 11778097 — intervention group
Group type: COMPARATOR
Intervention: Continuous cervical peridural anaesthesia with ropivacaine 0.5% 0.9 mg/kg and fentanyl 50-100 g
Number of subjects: 90
Study 9424681 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐tubocurarine 0.05 mg/kg
Number of subjects: 124
Study 9424681 — intervention group
Group type: EXPERIMENTAL
Intervention: atracurium 0.05 mg/kg
Number of subjects: 124
Study 9424681 — intervention group
Group type: EXPERIMENTAL
Intervention: vecuronium 0.01 mg/kg
Number of subjects: 124
Study 9424681 — intervention group
Group type: EXPERIMENTAL
Intervention: pancuronium 0.015 mg/kg
Number of subjects: 124
Study 7690527 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg bid
Number of subjects: 0
Study 7690527 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine, 240 mg bid
Number of subjects: 0
Study 7690527 — intervention group
Group type: COMPARATOR
Intervention: Ketotifen, 2 mg bid
Number of subjects: 0
Study 2867269 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum education programme
Number of subjects: 339
Study 2867269 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited education programme
Number of subjects: 339
Study 2867269 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 339
Study 31540572 — intervention group
Group type: EXPERIMENTAL
Intervention: CABG + MVR
Number of subjects: 76
Study 31540572 — intervention group
Group type: COMPARATOR
Intervention: Isolated CABG
Number of subjects: 76
Study 29474290 — intervention group
Group type: COMPARATOR
Intervention: Standard counseling (handout)
Number of subjects: 200
Study 29474290 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced video counseling (handout plus video)
Number of subjects: 200
Study 29474290 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 200
Study 27009342 — intervention group
Group type: COMPARATOR
Intervention: Environmental cleaning bundle (training, technique, product, audit, communication) implemented with environmental services staff
Number of subjects: 11
Study 27009342 — intervention group
Group type: COMPARATOR
Intervention: Environmental cleaning bundle
Number of subjects: 11
Study 27009342 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis of the cleaning bundle
Number of subjects: 11
Study 24832787 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating tumor cells (CTCs) detected before chemotherapy
Number of subjects: 2026
Study 24832787 — intervention group
Group type: EXPERIMENTAL
Intervention: Circulating tumor cells (CTCs) detected after chemotherapy
Number of subjects: 2026
Study 24832787 — intervention group
Group type: EXPERIMENTAL
Intervention: Presence of at least five CTCs per 30 mL blood
Number of subjects: 2026
Study 24832787 — intervention group
Group type: EXPERIMENTAL
Intervention: Persisting CTCs after chemotherapy
Number of subjects: 2026
Study 22503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum
Number of subjects: 147
Study 22503048 — intervention group
Group type: EXPERIMENTAL
Intervention: Collagenase Clostridium histolyticum with modeling
Number of subjects: 147
Study 22503048 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 147
Study 19781043 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 units of oxytocin
Number of subjects: 103
Study 19781043 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 units of oxytocin
Number of subjects: 103
Study 19781043 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 103
Study 17717284 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression management program (algorithm-based care)
Number of subjects: 584
Study 17717284 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 584
Study 16328744 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-consultation model social skills program (pre-K RECAP)
Number of subjects: 149
Study 16328744 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 149
Study 12692962 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy combined with radiation therapy of the involved field (specific chemotherapy regimen not detailed, but mentions CHOP cycles).
Number of subjects: 0
Study 12692962 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-course chemotherapy (3 cycles of CHOP) for low bulk tumors.
Number of subjects: 0
Study 12692962 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-course chemotherapy (6-8 cycles of CHOP) for larger tumors.
Number of subjects: 0
Study 12692962 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved field radiation (at least 30 Gy to sites in complete remission).
Number of subjects: 0
Study 10779656 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral dextromethorphan 150 mg
Number of subjects: 50
Study 10779656 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 10779656 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 8638465 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopically assisted vaginal hysterectomy (LH)
Number of subjects: 100
Study 8638465 — intervention group
Group type: COMPARATOR
Intervention: Total abdominal hysterectomy (TAH)
Number of subjects: 100
Study 1338225 — intervention group
Group type: EXPERIMENTAL
Intervention: Ganciclovir (12 patients)
Number of subjects: 23
Study 1338225 — intervention group
Group type: COMPARATOR
Intervention: Control (11 patients)
Number of subjects: 23
Study 6233379 — intervention group
Group type: EXPERIMENTAL
Intervention: Etretinate with whole milk (1 pint)
Number of subjects: 10
Study 6233379 — intervention group
Group type: COMPARATOR
Intervention: Etretinate with water
Number of subjects: 10
Study 3134905 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate treatment
Number of subjects: 28
Study 3134905 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 29396662 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight contact lenses
Number of subjects: 89
Study 29396662 — intervention group
Group type: COMPARATOR
Intervention: Single-vision spectacles
Number of subjects: 89
Study 28927442 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTI-BREAK programme (5-min bursts of moderate-intensity physical activity integrated into classroom routine, 3 times per day for 6 weeks)
Number of subjects: 6
Study 28927442 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTI-BREAK programme
Number of subjects: 6
Study 28927442 — intervention group
Group type: COMPARATOR
Intervention: Control group (no active breaks)
Number of subjects: 6
Study 26887521 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved treatment group (400 µg folic acid daily from the day before the first dose to 21 days after the last dose, 500 µg vitamin B12 injection one day before the first dose and before each therapy cycle)
Number of subjects: 283
Study 26887521 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment group (400 µg folic acid daily for 7 days before the first dose and continued until 21 days after the last dose, 1000 µg vitamin B12 injection at 7 days before the first dose and once per cycle for 3 cycles after the last dose)
Number of subjects: 283
Study 26887521 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved treatment group
Number of subjects: 283
Study 26887521 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment group
Number of subjects: 283
Study 26887521 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 283
Study 24280477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 26
Study 24280477 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupressure
Number of subjects: 26
Study 21174145 — intervention group
Group type: EXPERIMENTAL
Intervention: R 10 mg + FA 135 mg
Number of subjects: 456
Study 21174145 — intervention group
Group type: EXPERIMENTAL
Intervention: R 20 mg + FA 135 mg
Number of subjects: 456
Study 21174145 — intervention group
Group type: EXPERIMENTAL
Intervention: R 5 mg + FA 135 mg
Number of subjects: 456
Study 18312649 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐Administered Mailed Questionnaire (SAMQ)
Number of subjects: 599
Study 18312649 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer‐Assisted Self‐Interview (CASI)
Number of subjects: 599
Study 18312649 — intervention group
Group type: COMPARATOR
Intervention: Computer‐Assisted Telephone Interview (CATI)
Number of subjects: 599
Study 16970600 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (ZDV)
Number of subjects: 217
Study 16970600 — intervention group
Group type: COMPARATOR
Intervention: No ART
Number of subjects: 217
Study 16970600 — intervention group
Group type: COMPARATOR
Intervention: Other ART
Number of subjects: 217
Study 16970600 — intervention group
Group type: COMPARATOR
Intervention: Weight-based RBV dosing
Number of subjects: 217
Study 12720592 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral nutritional supplementation
Number of subjects: 20
Study 12720592 — intervention group
Group type: COMPARATOR
Intervention: Control group (no nutritional supplementation)
Number of subjects: 20
Study 12720592 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity level
Number of subjects: 20
Study 11096262 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulfurated mud baths (6 applications over 2 weeks)
Number of subjects: 25
Study 11096262 — intervention group
Group type: COMPARATOR
Intervention: Tap water baths (6 applications over 2 weeks)
Number of subjects: 25
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 3 mg kg-1 nasally (group IN3)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 9 mg kg-1 nasally (group IN9)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 9 mg kg-1 rectally (group IR9)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine 3 mg kg-1 i.v. (group IV3)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal ketamine (groups IN3 and IN9)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectal ketamine (group IR9)
Number of subjects: 32
Study 8881626 — intervention group
Group type: EXPERIMENTAL
Intervention: Norketamine after nasal administration
Number of subjects: 32
Study 1303639 — intervention group
Group type: EXPERIMENTAL
Intervention: Home visits from a nurse or social worker in addition to routine prenatal care (n = 1115)
Number of subjects: 2235
Study 1303639 — intervention group
Group type: COMPARATOR
Intervention: Routine prenatal care (n = 1120)
Number of subjects: 2235
Study 3890924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole (200 mg daily, doubled after 3 months if inadequate response)
Number of subjects: 74
Study 3890924 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin (500 mg daily, doubled after 3 months if inadequate response)
Number of subjects: 74
Study 3890924 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketoconazole
Number of subjects: 74
Study 3890924 — intervention group
Group type: COMPARATOR
Intervention: Griseofulvin
Number of subjects: 74
Study 3890924 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 74
Study 29338639 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous Passive Motion (CPM) combined with Complete Decongestive Therapy (CDT)
Number of subjects: 30
Study 29338639 — intervention group
Group type: COMPARATOR
Intervention: Complete Decongestive Therapy (CDT) alone
Number of subjects: 30
Study 27538770 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium-prepared platelet-rich fibrin (T-PRF)
Number of subjects: 0
Study 27538770 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 0
Study 24215171 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-288 (10 dose levels, from 1 to 60 mg once daily for 14 days)
Number of subjects: 67
Study 24215171 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-288
Number of subjects: 67
Study 24215171 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 67
Study 22873187 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic community program
Number of subjects: 468
Study 22873187 — intervention group
Group type: COMPARATOR
Intervention: Cognitive‐behavioral intervention
Number of subjects: 468
Study 20929341 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine supplemented with EPA and DHA (targeted additional daily intake of 400 mg of EPA-DHA)
Number of subjects: 4837
Study 20929341 — intervention group
Group type: EXPERIMENTAL
Intervention: Margarine supplemented with ALA (targeted additional daily intake of 2 g of ALA)
Number of subjects: 4837
Study 20929341 — intervention group
Group type: COMPARATOR
Intervention: Margarine supplemented with ALA compared to placebo and EPA-DHA alone in women
Number of subjects: 4837
Study 20929341 — intervention group
Group type: COMPARATOR
Intervention: Placebo margarine
Number of subjects: 4837
Study 18569679 — intervention group
Group type: EXPERIMENTAL
Intervention: True memories
Number of subjects: 0
Study 18569679 — intervention group
Group type: COMPARATOR
Intervention: False memories
Number of subjects: 0
Study 15763436 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostaglandin E1 (PGE1) infusion therapy
Number of subjects: 21
Study 15763436 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 21
Study 12858952 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccade-to-target task
Number of subjects: 2
Study 12858952 — intervention group
Group type: COMPARATOR
Intervention: Manual-target-detection task
Number of subjects: 2
Study 9987142 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose Mérieux BCG vaccine (lot E0650)
Number of subjects: 548
Study 9987142 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose Mérieux BCG vaccine (lot E0624)
Number of subjects: 548
Study 9987142 — intervention group
Group type: EXPERIMENTAL
Intervention: Full-dose WHO-reference vaccine (Tokyo strain 172)
Number of subjects: 548
Study 9987142 — intervention group
Group type: COMPARATOR
Intervention: 1/10 dose WHO-reference vaccine
Number of subjects: 548
Study 7489845 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin (n = 16; mean dose 30.0 +/- 12.6 mg/day)
Number of subjects: 34
Study 7489845 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 34
Study 7489845 — intervention group
Group type: EXPERIMENTAL
Intervention: Lovastatin
Number of subjects: 34
Study 7489845 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 34
Study 2227746 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical application of Ruscus extract (4 to 6 g of cream containing 64 to 96 mg Ruscus extract)
Number of subjects: 18
Study 2227746 — intervention group
Group type: COMPARATOR
Intervention: Placebo (base of the cream)
Number of subjects: 18
Study 369941 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulproston 500 microgram IM
Number of subjects: 50
Study 369941 — intervention group
Group type: EXPERIMENTAL
Intervention: Hegar's rods
Number of subjects: 50
Study 369941 — intervention group
Group type: COMPARATOR
Intervention: Physiological saline solution
Number of subjects: 50
Study 31536566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis, NAF
Number of subjects: 10119
Study 31536566 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialysis, non-NAF
Number of subjects: 10119
Study 31536566 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-Dialysis, NAF
Number of subjects: 10119
Study 31536566 — intervention group
Group type: COMPARATOR
Intervention: Non-Dialysis, non-NAF
Number of subjects: 10119
Study 31536566 — intervention group
Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis, AF
Number of subjects: 10119
Study 29653541 — intervention group
Group type: EXPERIMENTAL
Intervention: TARGIT-IORT (single-dose intra-operative radiotherapy)
Number of subjects: 0
Study 29653541 — intervention group
Group type: COMPARATOR
Intervention: EBRT (whole breast external beam radiotherapy)
Number of subjects: 0
Study 29653541 — intervention group
Group type: COMPARATOR
Intervention: Nurse and doctor scores
Number of subjects: 0
Study 26702749 — intervention group
Group type: EXPERIMENTAL
Intervention: Art therapy (6 painting sessions)
Number of subjects: 60
Study 26702749 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study 25456558 — intervention group
Group type: EXPERIMENTAL
Intervention: Setrobuvir 200 mg BID
Number of subjects: 0
Study 25456558 — intervention group
Group type: EXPERIMENTAL
Intervention: Setrobuvir 400 mg BID
Number of subjects: 0
Study 25456558 — intervention group
Group type: EXPERIMENTAL
Intervention: Setrobuvir 800 mg BID
Number of subjects: 0
Study 25456558 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 22013886 — intervention group
Group type: EXPERIMENTAL
Intervention: Telecare
Number of subjects: 241
Study 22013886 — intervention group
Group type: COMPARATOR
Intervention: Conventional self-monitored blood glucose (SMBG)
Number of subjects: 241
Study 22013886 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Telecare and SMBG)
Number of subjects: 241
Study 19280812 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal binder
Number of subjects: 54
Study 19280812 — intervention group
Group type: COMPARATOR
Intervention: No binder
Number of subjects: 54
Study 17849093 — intervention group
Group type: EXPERIMENTAL
Intervention: Stent‐supported angioplasty (CAS)
Number of subjects: 1214
Study 17849093 — intervention group
Group type: COMPARATOR
Intervention: Carotid endarterectomy (CEA)
Number of subjects: 1214
Study 15340127 — intervention group
Group type: EXPERIMENTAL
Intervention: lumiracoxib 400 mg/day
Number of subjects: 18
Study 15340127 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 18
Study 11595776 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat therapy
Number of subjects: 18
Study 9549655 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-ketoprofen 100 mg b.i.d.
Number of subjects: 72
Study 9549655 — intervention group
Group type: EXPERIMENTAL
Intervention: (R)-flurbiprofen 100 mg b.i.d.
Number of subjects: 72
Study 9549655 — intervention group
Group type: EXPERIMENTAL
Intervention: racemic ketoprofen 100 mg b.i.d.
Number of subjects: 72
Study 9549655 — intervention group
Group type: EXPERIMENTAL
Intervention: paracetamol 1,000 mg b.i.d.
Number of subjects: 72
Study 9549655 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study 7803063 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice models for applying the 1988 Adult Treatment Panel Guidelines
Number of subjects: 0
Study 3044276 — intervention group
Group type: EXPERIMENTAL
Intervention: Carboplatin regimen
Number of subjects: 42
Study 3044276 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin regimen
Number of subjects: 42
Study 31933034 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group (12-week exercise programme, twice per week)
Number of subjects: 32
Study 31933034 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise group
Number of subjects: 32
Study 31933034 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 32
Study 29320589 — intervention group
Group type: EXPERIMENTAL
Intervention: Test Product (novel hyaluronic acid gel)
Number of subjects: 0
Study 29320589 — intervention group
Group type: COMPARATOR
Intervention: Comparator (non‐animal stabilized hyaluronic acid gel)
Number of subjects: 0
Study 26786052 — intervention group
Group type: EXPERIMENTAL
Intervention: Wide-area circumferential pulmonary vein isolation (PVI)
Number of subjects: 40
Study 26786052 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeat electrophysiology study after 2 months
Number of subjects: 40
Study 25018057 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylene blue (260 mg)
Number of subjects: 42
Study 25018057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 22998856 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time myocardial contrast echocardiography (RTMCE)
Number of subjects: 1776
Study 22998856 — intervention group
Group type: COMPARATOR
Intervention: Non-RTMCE
Number of subjects: 1776
Study 22998856 — intervention group
Group type: EXPERIMENTAL
Intervention: RTMCE
Number of subjects: 1776
Study 20665986 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrysof IQ
Number of subjects: 260
Study 20665986 — intervention group
Group type: COMPARATOR
Intervention: Acrysof Natural
Number of subjects: 260
Study 17872406 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise before resistance training (BRT)
Number of subjects: 33
Study 17872406 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise after resistance training (ART)
Number of subjects: 33
Study 17872406 — intervention group
Group type: COMPARATOR
Intervention: Sedentary control (SED)
Number of subjects: 33
Study 16204298 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported appetite
Number of subjects: 1846
Study 12371383 — intervention group
Group type: EXPERIMENTAL
Intervention: ISDN‐80
Number of subjects: 15